Skip to main content

DM Max

NDC 63941-518 · Best Choice

Generic nameDEXTROMETHORPHAN HBr, GUAIFENESIN, PHENYLEPHRINE HCL
Dosage formSOLUTION
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN
Strength20; 400 mg/20mL; mg/20mL
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryOTC MONOGRAPH DRUG

Packages

63941-518-25 — 177 mL in 1 BOTTLE (63941-518-25)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63941-399 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 63941-455 — Dextromethorphan HBr, 63941-466 — Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, 63941-470 — Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, 63941-473 — Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl, 63941-497 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 63941-498 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 63941-499 — Dextromethorphan HBr, Doxylamine Succinate, 63941-509 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 63941-517 — DEXTROMETHORPHAN HBr, GUAIFENESIN, PHENYLEPHRINE HCL, 63941-731 — Guaifenesin, 63941-733 — Guaifenesin, Dextromethorphan HBr, 63941-734 — Guaifenesin, Dextromethorphan HBr, 63941-817 — Dextromethorphan Hydrobromide, Guaifenesin, 63941-823 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 63941-985 — Dextromethorphan Hydrobromide / Guaifenesin, 63941-986 — Guaifenesin/phenylephrine, 63941-987 — Guaifenesin, 63941-989 — Chlorpheniramine maleate, Dextromethorphan HBr, 63981-812 — dextromethorphan HBr, guaifenesin, +2508 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels